Inhibition of cellular growth and induction of apoptosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypericin: Potential therapeutic application

Journal of Neurosurgery

Volumn 85, Issue 2, 1996, Pages 329-334

  Hamilton, H Bruce ^b   Hinton, David R ^b   Law, Ronald E ^b   Gopalakrishna, Rayudu ^b   Su, Yu Zhuang ^b   Chen, Zhen Hai ^b   Weiss, Martin H ^b   Couldwell, William T ^a  

^a Trinity Health Minot   (United States)

^b NONE

Author keywords

apoptosis; hypericin; pituitary adenoma; protein kinase C

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DITHIOTHREITOL; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; HYPERICIN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; STAUROSPORINE; TAMOXIFEN; TRYPAN BLUE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HYPOPHYSIS ADENOMA; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0030036743     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.85.2.0329     Document Type: Article

References (38)

1. 1 cells. J Biol Chem 269:4653-4660, 1994
2. 1 cells. Biochem Biophys Res Commun 172:184-189, 1990
3. Alvaro V, Lévy L. Dubray C, et al: Invasive human pituitary tumors express a point-mutated α-protein kinase-C. J Clin Endocrinol Metab 77:1125-1129, 1993
4. Alvaro V, Touraine P, Raisman Vozari R, et al: Protein kinase C activity and expression in normal and adenomatous human pituitaries. Int J Cancer 50:724-730, 1992
5. Andersen DO, Weber ND, Wood SG, et al: In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives. Antiviral Res 16:185-196, 1991
6. Anker L, Gopalakrishna R, Jones KD, et al: Hypericin in adjuvant brain tumor therapy. Drugs Fut 20:511-517, 1995
7. Baltuch G, Couldwell WT, Villemure JG, et al: Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen. Neurosurgery 33:495-501, 1993
8. Couldwell WT, Antel JP, Apuzzo MLJ, et al: Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system. J Neurosurg 73:594-600, 1990
9. Couldwell WT, Antel JP, Yong VW: Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C. Neurosurgery 31:717-724, 1992
10. Couldwell WT, Gopalakrishna R, Hinton DR, et al: Hypericin: a potential antiglioma therapy. Neurosurgery 35:705-710, 1994
11. Couldwell WT, Hinton DR, He S, et al: Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett 345:43-46, 1994
12. Couldwell WT, Law RE, Hinton DR, et al: Protein kinase C and growth regulation of pituitary adenomas. Acta Neurochir (Suppl) 65:22-26, 1996
13. Couldwell WT, Weiss MH, Law RE, et al: Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas. J Neurosurg 82:461-468, 1995
14. Daniel C: Further communications on the photodynamic substance hypericin. Hippokrates 19:526-530, 1949
15. Dekker LV, Parker PJ: Protein kinase C - a question of specificity. Trends Biochem Sci 19:73-77, 1994
16. de Witte P, Agostinis P, Van Lint J, et al: Inhibition of epidermal growth factor receptor tyrosine kinase activity by hypericin. Biochem Pharmacol 46:1929-1936, 1993
17. Diwu Z, Lown JW: Photosensitization with anticancer agents 17. EPR studies of photodynamic action of hypericin: formation of semiquinone radical and activated oxygen species on illumination. Free Radic Biol Med 14:209-215, 1993
18. Durán N. Song PS: Hypericin and its photodynamic action. Photochem Photobiol 43:677-680, 1986
19. 1 pituitary cells. J Biol Chem 260:8366-8371, 1985
20. Hartwell JL: Plants Used Against Cancer. A Survey. Lawrence, MA: Quarterman Publications, 1982, pp 239-241
21. Hudson JB, Lopez-Bazzocchi I, Towers GHN: Antiviral activities of hypericin. Antiviral Res 15:101-112, 1991
22. Hudson JB, Towers GHN: Therapeutic potential of plant photosensitizers. Pharmacol Ther 49:181-222, 1991
23. Ison AJ, MacEwan DJ, Johnson MS, et al: Evidence for a distinct H7-resistant form of protein kinase C in rat anterior pituitary gland. FEBS Lett 329:199-204, 1993
24. Jin L, Maeda T, Chandler WF, et al: Protein kinase C (PKC) activity and PKC messenger RNAs in human pituitary adenomas. Am J Pathol 142:569-578, 1993
25. Johnson MS, MacEwan DJ, Simpson J, et al: Characterisation of protein kinase C isoforms and enzymic activity from the αT3-1 gonadotroph-derived cell line. FEBS Lett 333:67-72, 1993
26. 1 cells. J Biol Chem 266:23761-23768, 1991
27. 1 cells. Mol Endocrinol 6:120-131, 1992
28. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
29. Nishizuka Y: The molecular heterogeneity of protein kinase C and its implications for cellular recognition. Nature 334: 661-665, 1988
30. 7 cells: involvement of protein kinase-C∈. Endocrinology 134:783-789, 1994
31. Suzuki O, Katsumata Y, Oya M, et al: Inhibition of monoamine oxidase by hypericin. Planta Med 50:272-274, 1984
32. Takahashi I, Nakanishi S, Kobayashi E, et al: Hypericin and pseudohypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity. Biochem Biophys Res Commun 165:1207-1212, 1989
33. Tang J, Colacino JM, Larsen SH, et al: Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses. Antiviral Res 13:313-326, 1990
34. Thomas C, MacGill RS, Miller GC, et al: Photoactivation of hypericin generates singlet oxygen in mitochondria and inhibits succinoxidase. Photochem Photobiol 55:47-53, 1992
35. Thomson FJ, Johnson MS, Mitchell R, et al: The differential effects of protein kinase C activators and inhibitors on rat anterior pituitary hormone release. Mol Cell Endocrinol 94: 223-234, 1993
36. Todo T, Buchfelder M, Thierauf P, et al: Immunohistochemical expression of protein kinase C type III in human pituitary adenomas. Neurosurgery 32:635-642, 1993
37. Twentyman PR, Luscombe M: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56:279-285, 1987
38. van de Loosdrecht AA, Beelen RHJ, Ossenkoppele GJ, et al: A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods 174:311-320, 1994